S&P Futures
4,033.75 -2.00 (-0.05%) Dow Futures
32,743.00 -31.00 (-0.09%) Nasdaq Futures
12,869.00 +1.75 (+0.01%) Russell 2000 Futures
1,793.10 -0.20 (-0.01%) Crude Oil
69.50 +0.17 (+0.25%) Gold
1,947.90 +6.80 (+0.35%)
Fate Therapeutics, Inc. (FATE)
After hours:
Chart Events
Performance Outlook
| Previous Close | 5.56 |
| Open | 5.61 |
| Bid | 5.44 x 1200 |
| Ask | 5.75 x 1800 |
| Day's Range | 5.38 - 5.61 |
| 52 Week Range | 4.02 - 43.12 |
| Volume | |
| Avg. Volume | 4,213,211 |
| Market Cap | 526.664M |
| Beta (5Y Monthly) | 1.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.11 |
| Earnings Date | May 02, 2023 - May 08, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 8.77 |
- GlobeNewswire
Fate Therapeutics to Present at Upcoming March Investor Conferences
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will participate in the following upcoming investor conferences: 43rd Annual TD Cowen Health Care Conference on Wednesday, March
- Insider Monkey
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript
Fate Therapeutics, Inc. (NASDAQ:FATE) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Welcome to the Fate Therapeutics Fourth Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. This call is being webcast live on the Investors section of Fate’s website at fatetherapeutics.com. As a reminder, today’s call […]
- Simply Wall St.
Fate Therapeutics Full Year 2022 Earnings: Beats Expectations
Fate Therapeutics ( NASDAQ:FATE ) Full Year 2022 Results Key Financial Results Revenue: US$96.3m (up 72% from FY 2021...
